AI Summary & Key Takeaways
AI InsightSince adjuvant chemotherapy and radiotherapy in the treatment management of the disease is controversial, it was decided to follow up without adjuvant therapy after surgery.
📌 3 Key Takeaways
Abstract
Less than 200 cases of para-testicular liposarcoma have been reported. Testicular liposarcoma may present with painless or painful intra-scrotal or inguinoscrotal mass of long duration or recent onset but the most common presentation is a painless mass. We present a 58-year-old male patient who presented with the complaint of painless swelling in the right hemiscrotum. Initially, a clinical diagnosis of testicular tumor was made; however, doppler ultrasonography of the scrotum showed paratesticular tumor. Right scrotal orchiectomy was performed and a diagnosis of liposarcoma was made. Histopathological studies confirmed the diagnosis of well-differentiated liposarcoma (atypical lipomatous tumor). No distant metastasis was evident in the whole-body PET-CT scan. Since adjuvant chemotherapy and radiotherapy in the treatment management of the disease is controversial, it was decided to follow up without adjuvant therapy after surgery.
Özet
Less than 200 cases of para-testicular liposarcoma have been reported. Testicular liposarcoma may present with painless or painful intra-scrotal or inguinoscrotal mass of long duration or recent onset but the most common presentation is a painless mass. We present a 58-year-old male patient who presented with the complaint of painless swelling in the right hemiscrotum. Initially, a clinical diagnosis of testicular tumor was made; however, doppler ultrasonography of the scrotum showed paratesticular tumor. Right scrotal orchiectomy was performed and a diagnosis of liposarcoma was made. Histopathological studies confirmed the diagnosis of well-differentiated liposarcoma (atypical lipomatous tumor). No distant metastasis was evident in the whole-body PET-CT scan. Since adjuvant chemotherapy and radiotherapy in the treatment management of the disease is controversial, it was decided to follow up without adjuvant therapy after surgery.